Schedule 13G ownership disclosure

Vaxcyte Inc

Common Stock · CUSIP: 92243G108

Event date: 2025-03-31

Filing-level shares
9,825,638
Percent of class
7.6%
  • BlackRock, Inc.

    Shares: 9,825,638 · Class: 7.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001576419-25-000666
Form type
SCHEDULE 13G/A
Filer
BlackRock, Inc.
CIK
CIK 2012383
Filed
Apr 17, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub